Navigation Links
Federal funding gap cited for research on human health impacts due to climate change
Date:3/26/2009

March 26, 2009 -- Climate change will seriously impact public health, but the United States has yet to allocate adequate research funding to understand and prepare for these impacts, according to a report published in Environmental Health Perspectives, the journal of the U.S. National Institute of Environmental Health Sciences. The report suggests that the current knowledge gap regarding climate change and public health is putting multitudes at risk and calls for a major expansion of research to tackle this problem.

The report emphasizes that global warming is expected to worsen many health problems, including heat-related mortality, diarrheal diseases, and diseases associated with exposure to ozone and allergens from the air. Health effects are also likely to result from altered air, water, agriculture, and ecosystems processes, according to the report.

"This paper highlights the gap in our understanding of current impacts of climate on health, and how those impacts may amplify in the future," says report author Patrick Kinney, ScD, associate professor of Environmental Health Sciences and director of the Program in Climate and Health at the Mailman School of Public Health, which is at the forefront of research on climate and health. "Such knowledge is critical if we are to invest wisely in preventive and adaptive responses now that can avert enormous human and financial costs later."

Despite these facts, federal funding of health research related to climate change is estimated to be less than $3 million per year. This level of U.S. funding, the report states, "appears to be due to the low priority placed on identifying and managing the health risks of climate change by Congress and the Federal government." The report estimates that more than $200 million is needed annually to sponsor "robust intra- and extramural programs" in federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and U.S. Environmental Protection Agency.

Funding research on climate change and health "that is directly linked to protective action at the local level is a wise investment, consistent with the goals of restoring economic stability, justice and environmental quality, and reducing healthcare costs," the report states.

The report is co-written by the same authors who wrote the Climate Change and Human Health chapter in the July 2008 U.S. Environmental Protection Agency report: "Analyses of the Effects of Global Change on Human Health and Welfare and Human Systems." In addition to Dr. Kinney of the Mailman School of Public Health, the authors are from the Environmental Defense Fund, the University of Georgia, the University of Michigan, and Stratus Consulting, Inc.

In recognition of the critical importance of climate change and its adverse effects on health, the Mailman School of Public Health established a Program on Climate and Health in early 2009 led by Dr. Patrick Kinney to provide coordination and leadership to address these issues.


'/>"/>

Contact: stephanie berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Related medicine news :

1. Federal Court Rules FDA Must Reconsider Plan B Decision
2. PIPC Statement on Federal CER Coordinating Council
3. Medicines small business practices should be supported by federal budget
4. German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI
5. HIPAA Amendments in Federal Stimulus Bill Explained During Critical Health Care Compliance Association Two-Part Web Conference
6. Health Integrated Launches Unique Service for Health Plans Preparing for Federal Mental Health Parity Regulations
7. The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager
8. Midwestern and Southern States Receive Least Federal Funding for Disease Prevention
9. Consumer Group Wants Public to Share Profits From Federally Funded Stem Cell and Medical Research
10. Christopher & Dana Reeve Foundation Commends President Obamas Decision to Lift Federal Restrictions on Stem Cell Research
11. SAICs K. Stuart Shea Named Federal 100 Winner by Federal Computer Week
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: